SNB 2023 Zürich

106.1K kr SEK

Funder	Vinnova
Recipient Organization	Combigene Ab
Country	Sweden
Start Date	Mar 29, 2023
End Date	Mar 31, 2023
Duration	2 days
Number of Grantees	1
Roles	Principal Investigator
Data Source	Swedish Research Council
Grant ID	`2023-00198_Vinnova`

Grant Description

Purpose and goal:

Objective: To establish contact with new Life Science investors as well as with "Big Pharma" companies. In addition, to follow up already established contacts. Results: Several important investor contacts were followed up and a couple of new ones were established. No for us interesting "Big Pharma" companies participated.

Expected results and effects:

I identified and established contact with new potential investors and also had the opportunity to update investors we already have contact with. Approach and implementation:

I traveled to Zurich on 29/3, participated on 30/3 in partnering activities and presented CombiGene to approx. 75-100 employees. There were also good opportunities to listen to other company presentations and to network. Return trip on 31/3. Very well planned and executed event.